MeSH D012871 - skin diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D017437:Skin and connective tissue diseases
0 Companies
0 Drugs
Success rate
D012871:Â
Skin diseases
D000796:Angiolymphoid hyperplasia with eosinophilia
0 Companies
0 Drugs
Success rate
D003872:Dermatitis
D003882:Dermatomyositis
D004890:Erythema
0 Companies
0 Drugs
Success rate
D005076:Exanthema
0 Companies
0 Drugs
Success rate
D005148:Facial dermatoses
D005534:Foot diseases
0 Companies
0 Drugs
Success rate
D006201:Hair diseases
0 Companies
0 Drugs
Success rate
D006229:Hand dermatoses
D007636:Keratoacanthoma
0 Companies
0 Drugs
Success rate
D007642:Keratosis
D007868:Leg dermatoses
D008068:Lipomatosis
0 Companies
0 Drugs
Success rate
D008178:Cutaneous lupus erythematosus
0 Companies
0 Drugs
Success rate
D009260:Nail diseases
0 Companies
0 Drugs
Success rate
D010787:Photosensitivity disorders
D010859:Pigmentation disorders
0 Companies
0 Drugs
Success rate
D011537:Pruritus
D011711:Pyoderma
0 Companies
0 Drugs
Success rate
D012393:Rosacea
D012536:Scalp dermatoses
D012592:Scleredema adultorum
0 Companies
0 Drugs
Success rate
D012594:Localized scleroderma
0 Companies
0 Drugs
Success rate
D012595:Systemic scleroderma
D012625:Sebaceous gland diseases
0 Companies
0 Drugs
Success rate
D012868:Skin abnormalities
0 Companies
0 Drugs
Success rate
D012872:Vesiculobullous skin diseases
0 Companies
0 Drugs
Success rate
D012873:Genetic skin diseases
D012874:Infectious skin diseases
D012875:Metabolic skin diseases
0 Companies
0 Drugs
Success rate
D012878:Skin neoplasms
D012883:Skin ulcer
D013543:Sweat gland diseases
0 Companies
0 Drugs
Success rate
D014972:Juvenile xanthogranuloma
0 Companies
0 Drugs
Success rate
D015434:Panniculitis
0 Companies
0 Drugs
Success rate
D017441:Necrobiotic disorders
0 Companies
0 Drugs
Success rate
D017443:Eczematous skin diseases
0 Companies
0 Drugs
Success rate
D017445:Vascular skin diseases
0 Companies
0 Drugs
Success rate
D017577:Cutaneous fistula
0 Companies
0 Drugs
Success rate
D054989:Nephrogenic fibrosing dermopathy
0 Companies
0 Drugs
Success rate
D055535:Morgellons disease
0 Companies
0 Drugs
Success rate
D058568:Necrolytic migratory erythema
0 Companies
0 Drugs
Success rate
D000092182:Calcinosis cutis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Padagis | Bacitracin, Polymyxin b | Bacitracin Polymyxin B |  | 2002-02-27 |  |  |
| Hydrocortisone, Bacitracin, Neomycin, Polymyxin b | Bacitracin-neomycin-polymyxin W/ Hydrocortisone |  | 1982-01-01 |  |  | |
| Bacitracin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Bacitracin |  | 1982-01-01 |  |  | |
| Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone |  | 1989-07-31 |  |  | |
| GSK | Polymyxin b | Aerosporin |  | 1982-01-01 |  |  |
| Neomycin, Polymyxin b | Neosporin |  | 1985-01-14 |  |  | |
| Bacitracin, Polymyxin b | Polysporin |  | 1985-03-01 |  |  | |
| Sandoz | Dexamethasone, Neomycin, Polymyxin b | Maxitrol |  | 1984-05-22 |  |  |
| Hydrocortisone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Hydrocortisone |  | 1983-08-25 |  |  | |
| Trimethoprim, Polymyxin b | Trimethoprim Polymyxin B |  | 1998-04-13 |  |  | |
| Novartis | Dexamethasone, Neomycin, Polymyxin b | Dexacidin |  | 1984-10-29 |  |  |
| Bausch Health Companies | Bacitracin, Polymyxin b | Bacitracin Polymyxin B |  | 1995-01-26 |  |  |
| Dexamethasone, Neomycin, Polymyxin b | Dexasporin |  | 1995-09-13 |  |  | |
| Bacitracin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Bacitracin |  | 1995-10-30 |  |  | |
| Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone |  | 1994-07-25 |  |  | |
| Gramicidin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Gramicidin |  | 1996-01-31 |  |  | |
| Hydrocortisone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Hydrocortisone |  | 1995-12-29 |  |  | |
| Hydrocortisone, Bacitracin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates, Bacitracin Hydrocortisone |  | 1995-10-30 |  |  | |
| Hydrocortisone, Neomycin, Polymyxin b | Oticair |  | 1996-08-28 |  |  | |
| Trimethoprim, Polymyxin b | Trimethoprim Polymyxin B |  | 1997-02-14 |  |  | |
| Merck & Co | Hydrocortisone, Neomycin, Polymyxin b | Otobione |  | 1982-01-01 |  |  |
| Hydrocortisone, Polymyxin b | Otobiotic |  | 1982-01-01 |  |  | |
| Allergan | Prednisolone, Neomycin, Polymyxin b | Poly-pred |  | 1982-01-01 |  |  |
| Trimethoprim, Polymyxin b | Polytrim |  | 1988-10-20 |  |  | |
| Neomycin, Polymyxin b | Neomycin Polymyxin B |  | 1986-04-08 |  |  | |
| Gramicidin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Gramicidin |  | 1987-06-11 |  |  | |
| Hydrocortisone, Neomycin, Polymyxin b | Otocort |  | 1982-01-01 |  |  | |
| Pfizer | Chloramphenicol, Polymyxin b | Chloromyxin |  | 1982-01-01 |  |  |
| Oxytetracycline, Polymyxin b | Terramycin W/ Polymyxin |  | 1982-01-01 |  |  | |
| Oxytetracycline, Polymyxin b | Terramycin-polymyxin |  | 1982-01-01 |  |  | |
| Rising Pharmaceuticals | Polymyxin b | Polymyxin B |  | 2011-06-29 |  |  |
| Forest Laboratories | Hydrocortisone, Polymyxin b | Pyocidin |  | 1982-01-01 |  |  |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
33%1/3
Phase 2
7%1/14
Phase 3
44%7/16
Approved: 7Overall Success rate: 1%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use